Sung Lab

Anthony D. Sung, MD, Primary Investigator

Anthony D. Sung, MD

Assistant Professor of Medicine
Member of the Duke Cancer Institute
 

Education

Fellowship, Hematology Oncology, Duke University School of Medicine, 2011 - 2014
Residency, Osler Medical Housestaff Training Program, Johns Hopkins University School of Medicine, 2008 - 2011
M.D., Harvard University , 2008

Research in the Sung lab focuses on strategies to reduce complications of HCT and ranges from preclinical studies using murine models of HCT to Phase 1 and Phase 2 clinical trials.

Lab Members

Megan Covington
Lab Research Analyst, Senior

Amy Bush 
Lab Research Analyst I

Cong-Xiao Liu
Research Scientist, Senior

Shara Reihani
Research Program Leader, Sr

Krista Nichols
Clinical Specialist

Kristi Romero
Clinical Research Coordinator, Tier 1

Yen Lowder
Clinical Research Coordinator, Tier 1

Lauren Bohannon
Clinical Research Coordinator, Tier 1

Meagan Lew
Clinical Research Coordinator, Tier 1

Jill Thompson
Clinical Research Specialist, Sr

Anthony Ranasinghe
Clinical Research Specialist, Sr

Yi Ren
Biostatistician II

KoKo Maung
House Staff

Vinay Giri
MED3 Graduate Student

Kristin Kajcienski
Non-Duke Undergraduate Student

Current Studies

I am dedicated to the treatment of hematologic malignancies through cellular therapies such as hematopoietic stem cell transplantation (HCT). My research focuses on strategies to reduce complications of HCT and ranges from preclinical studies using murine models of HCT to Phase 1 and Phase 2 clinical trials. Areas of interest include the role of the microbiota (the trillions of bacteria living in and on our bodies), nutrition, and exercise in modulating HCT outcomes such as graft-versus-host disease (GVHD) and infections. In addition to advancing new pharmacological and cellular immunotherapies in support of these goals, we also are developing mobile health technologies (mHealth) to monitor patients at home, both as part of our innovative home transplant program as well as to improve follow up care of all our patients when they return home after transplant.